Two Sigma Securities’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$659K Buy
+11,192
New +$683K 0.05% 467

Other funds holding TVTX

Two Sigma Securities's TVTX Position: Q3 2026 in Review

Two Sigma Securities opened a new position in Travere Therapeutics (TVTX) in Q3 2026: 11,192 shares worth $659K. The stake represents 0.05% of the portfolio and ranks #467 among its holdings.

343 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

  • Two Sigma Securities held 11,192 shares of Travere Therapeutics worth $659K as of Q3 2026.
  • Travere Therapeutics was a new Two Sigma Securities position in Q3 2026.
  • Travere Therapeutics made up 0.05% of Two Sigma Securities's portfolio in Q3 2026, its #467 holding.
  • 343 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.